Efficacy comparison of immune treating strategies for NSCLC patients with negative PD-L1 expression.

Kaiyue DingMinhan YiHui LiangZhongkui LiYuan Zhang

Published in: Expert review of clinical immunology (2022)

Both single ICI plus chemotherapy and doublet ICIs were probably better treatment decisions than chemotherapy alone for negative PD-L1 NSCLC patients. Also, single ICI plus radiotherapy carved out a new strategy.

Keyphrases

locally advanced
small cell lung cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
advanced non small cell lung cancer
early stage
radiation therapy
prognostic factors
peritoneal dialysis
squamous cell carcinoma
rectal cancer
radiation induced
tyrosine kinase